Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways

Yingli Cui1, Xin Chen2, Wenjie Li3

  • 1Department of Gynecologic Oncology, First Hospital of Jilin University, Changchun 130021, PR China.

Translational Oncology
|August 2, 2024
PubMed
Abstract

Insights

Recombinant adenovirus Ad-apoptin-hTERTp-E1a (Ad-VT) effectively inhibits ovarian cancer cells by inducing apoptosis and autophagy. This oncolytic virus shows significant antitumor effects in vivo, offering a promising therapeutic strategy.

Area of Science:

  • Oncolytic virology
  • Cancer biology
  • Molecular oncology

Background:

  • Recombinant adenovirus Ad-apoptin-hTERTp-E1a (Ad-VT) exhibits bi-specific oncolytic activity.
  • The precise mechanisms of Ad-VT-induced tumor cell death remain incompletely understood.
  • Investigating the interplay between apoptosis and autophagy in Ad-VT's action is crucial.

Purpose of the Study:

  • To elucidate the apoptosis and autophagy mechanisms induced by Ad-VT in ovarian cancer cells.
  • To explore the interaction between autophagy and apoptosis pathways during Ad-VT treatment.
  • To evaluate the therapeutic potential of Ad-VT against ovarian cancer.

Main Methods:

  • In vitro assays (Crystal Violet staining, CCK-8) assessed Ad-VT's effect on ovarian cancer cells.
  • In vivo studies utilized a tumor-bearing nude mouse model to evaluate antitumor efficacy.
  • Flow cytometry and fluorescence staining (LC3) analyzed apoptosis and autophagy levels.

Main Results:

  • Ad-VT demonstrated significant inhibition of ovarian cancer A2780 cells with minimal impact on normal cells.
  • In vivo experiments confirmed Ad-VT's tumor growth inhibition and survival extension in mice.
  • Ad-VT induced significant apoptosis via the endogenous pathway and increased protective autophagy in cancer cells.

Conclusions:

  • Ad-VT effectively targets and inhibits ovarian cancer A2780 cells.
  • The virus promotes both apoptosis and autophagy, contributing to its oncolytic effect.
  • Ad-VT represents a potential therapeutic agent for ovarian cancer treatment.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.3K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K